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http://dx.doi.org/10.1016/j.stemcr.2017.05.020Embryonic stem cells (ESCs) are a unique tool for genetic pertur-
bation of mammalian cellular and organismal processes addition-
ally in humans offer unprecedented opportunities for disease
modeling and cell therapy. Furthermore, ESCs are a powerful sys-
tem for exploring the fundamental biology of pluripotency. Indeed
understanding the control of self-renewal and differentiation is
key to realizing the potential of ESCs. Building on previous obser-
vations, we found thatmouse ESCs can be derived andmaintained
with high efficiency through insulation from differentiation cues
combined with consolidation of an innate cell proliferation
program. This finding of a pluripotent ground state has led to con-
ceptual and practical advances, including the establishment of
germline-competent ESCs from recalcitrant mouse strains and for
the first time from the rat. Here, we summarize historical and
recent progress in defining the signaling environment that
supports self-renewal. We compare the contrasting requirements
of two types of pluripotent stem cell, naive ESCs and primed
post-implantation epiblast stem cells (EpiSCs), and consider the
outstanding challenge of generating naive pluripotent stem cells
from different mammals.Nurture of Pluripotent Embryonic Stem Cells
The study of pluripotency began with the discovery of a
strain of mice that spontaneously developed teratocarci-
noma (Stevens and Little, 1954). Thesemulti-differentiated
tumors comprise derivatives of all germ layers along with
an undifferentiated proliferative compartment. The primi-
tive proliferative cells, called embryonal carcinoma (EC)
cells, could be propagated in culture and remain pluripo-
tent (Martin, 1980). However, EC cells are karyotypically
abnormal and tumorigenic (Silver et al., 1983). Fortunately,
culture conditions optimized for EC cells subsequently
allowed the derivation of pluripotent stem cells directly
from pre-implantation mouse embryos (Evans and Kauf-
man, 1981; Martin, 1981). These embryonic stem cells
(ESCs) were genetically normal and exhibited the remark-
able capacity to contribute extensively to chimeric mice
without forming tumors (Bradley et al., 1984). Moreover,
ESCs could colonize the germline in chimaeras, heralding
the era of targeted manipulation of the mouse genome
(Capecchi, 2005).
ESCs were originally derived by co-culture with a feeder
layer of mitotically inactivated fibroblasts in medium con-
taining fetal calf serum. These empirical culture conditions
are effective for deriving and propagating ESCs from theStem Cel
This is an open access artiinbred 129 strain of mice, but less so or not at all for other
strains. Eventually it was found that feeders could be re-
placed by the cytokine leukemia inhibitory factor (LIF)
(Smith et al., 1988; Smith and Hooper, 1987; Williams
et al., 1988) and that serum could be substituted by bone
morphogenetic protein (BMP) (Ying et al., 2003). These
findings provided a defined culture condition but did not
enable generic derivation of ESCs from different mouse
strains. nor did they maintain homogeneous cultures.
LIF signaling is not essential for pluripotency in vivo
(Stewart et al., 1992), except during facultative diapause
(Nichols et al., 2001). This observation suggested that it
should be possible to bypass the requirement of ESCs for
LIF. LIF supports ESC self-renewal through receptor-medi-
ated stimulation of Janus-associated kinase (JAK) and
activation of the transcription factor Stat3 (Niwa et al.,
1998). LIF also activates the mitogen-activated protein
kinase (Erk) cascade, but this is dispensable for self-renewal.
To the contrary, we found that inhibition of Erk activation
actually promoted the self-renewal response (Burdon et al.,
1999). However, pharmacological or genetic suppression of
Erk signaling was not sufficient to sustain ESCs long-term
or clonally without LIF (Wray et al., 2010). We therefore
investigated alternative signaling pathways.
It had been reported that simulation ofWnt signaling by
inhibition of glycogen synthase kinase 3 (GSK3) could sup-
port ESC self-renewal (Sato et al., 2004). Interpretation of
those studies was uncertain, however, because the indiru-
bin class of GSK3 inhibitors displayed pleiotropic off-target
effects and the available recombinant Wnt had a compara-
tively weak effect that appeared to rely on synergy with LIF
(Hao et al., 2006; Ogawa et al., 2006). Following advice
from Philip Cohen (University of Dundee), we obtained a
more selective GSK3 inhibitor, CHIR99021 (CHIR) (Bain
et al., 2007). Using titrated CHIR we found that partial
inhibition of GSK3 had a short-term stimulatory effect on
ESC self-renewal in the absence of LIF and serum. We
then combined CHIR with blockade of the Erk pathway,
initially using inhibitors of both the Erk activating en-
zymesMEK1/2, and of the fibroblast growth factor (FGF) re-
ceptor. This three-inhibitor combination (3i) was sufficient
to derive and maintain mouse ESCs without LIF or serum
and even upon genetic deletion of Stat3 (Ying et al.,
2008). We subsequently noted that a more potent MEKl Reports j Vol. 8 j 1457–1464 j June 6, 2017 j ª 2017 The Authors. 1457
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the FGF receptor inhibitor dispensable. The two-inhibitor
(2i) combination has since been widely adopted. These
two inhibitors effectively shut down differentiation path-
ways in naive cells while preserving their intrinsic meta-
bolic and proliferative program (Figure 1).
Importantly, although 2i allows strain 129 ESC propaga-
tion independently of LIF/Stat3 activity, addition of LIF
gives superior clonal propagation (Wray et al., 2010) and
may be crucial for expansion in other strains. Indeed a
key advance enabled by culture in 2i/LIF without serum
is the ability to derive germline-competent ESCs from
different mouse strains (Nichols et al., 2009) and even
from a different species, the rat (Buehr et al., 2008; Li
et al., 2008). Thus use of 2i/LIF revealed that ESC derivation
is a generic feature in mice and rats and not an artifact of
a specific inbred background. Furthermore, molecular
reprogramming of mouse somatic cells into induced
pluripotent stem cells (Takahashi and Yamanaka, 2006) is
facilitated by 2i/LIF (Silva et al., 2008).1458 Stem Cell Reports j Vol. 8 j 1457–1464 j June 6, 2017Molecular Circuitry of Mouse ESC Self-Renewal
The POU homeodomain transcription factor Oct4 and the
HMG-box transcription factor Sox2 are considered to lie at
the heart of pluripotency gene regulatory networks (Niwa,
2014; Young, 2011). Strikingly, however, neither LIF nor 2i
appear to regulate these factors directly. Research over
several years has identified several transcription factor
target genes of Stat3 in ESCs, including Klf4, Tfcp2l1, and
Gbx2 (Bourillot et al., 2009; Hall et al., 2009; Martello
et al., 2013; Niwa et al., 2009; Tai and Ying, 2013; Ye
et al., 2013, 2016). These three targets are each individually
capable of mimicking the self-renewal-promoting effect of
Figure 1. Capture of a Stem Cell State by
Suspending Developmental Progression
A generic scheme illustrating the idea that
self-renewal can ensue if the core transcrip-
tion factor (TF) network is insulated from
differentiation cues and requisite metabolic
conditions are satisfied. In the specific case
of the mouse ESC ground state, the 2i in-
hibitors block FGF/Erk and Tcf3 differentia-
tion pathways, while LIF boosts the core TF
network and also promotes metabolic activ-
ity, as does GSK3 inhibition. In the absence
of 2i/LIF components, the ESC gene regula-
tory circuitry collapses and cells transition
toward lineage priming and differentiation.
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PerspectiveLIF when overexpressed. GSK3 inhibition also upregulates
several transcription factors with self-renewal activity.
GSK3 exists in two isoforms a and b, both of which are
inhibited by CHIR. Treatment of ESCs with CHIR leads to
induction of Esrrb, Nanog, and Tfcp2l1 (Martello et al.,
2012; Ye et al., 2013). The mechanism has been debated,
but genetic evidence indicates that critical mediators are
b-catenin and Tcf3 (Guo et al., 2011; Lyashenko et al.,
2011; Pereira et al., 2006; Wray et al., 2011; Ye et al.,
2017). GSK3 inhibition stabilizes intracellular b-catenin,
which is known to bind Tcf3 and relieve its repressive ac-
tion at target genes (Shy et al., 2013; Wray et al., 2011; Yi
et al., 2011). Thus the potent impact of LIF and CHIR on
ESC self-renewal can largely be explained by combinatorial
induction and derepression, respectively, of components of
the pluripotency gene regulatory network (Dunn et al.,
2014; Martello and Smith, 2014). In addition, however,
LIF/Stat3 has pro-proliferative and metabolic effects that
may be independent of induction of pluripotency factors
(Carbognin et al., 2016). We have also noted that b-catenin
null ESCs still respond to CHIR with a modest enhance-
ment of self-renewal efficiency (Wray et al., 2011). GSK3
negatively regulates many targets other than b-catenin
and acts broadly to suppress anabolic pathways (Doble
and Woodgett, 2003). Therefore, inhibition of GSK3 can
have a general growth-promoting effect, which may be
particularly significant in a serum or growth factor-free
environment and upon inhibition of Erk signaling.
The contribution of Erk pathway inhibition to ESC self-
renewal also appears to bemulti-factorial. There is evidence
that active Erk can repress expression of Nanog (Hamazaki
et al., 2006; Silva et al., 2009) and can inactivate Klf2 (Yeo
et al., 2014). Therefore, Mek inhibition can increase the ac-
tivity of these two self-renewal factors in the ESC network.
However, Erk signalingmay also actively promote develop-
mental progression out of the ESC state (Kalkan and Smith,
2014; Kunath et al., 2007; Stavridis et al., 2007). Active Erkstimulates RNA polymerase, which may globally increase
transcriptional noise as a basis for cell decision making,
and/or be targeted to upregulate developmental genes
(Tee et al., 2014). We additionally hypothesize, however,
that Erk selectively induces or activates specific factors
that mediate transition from the ESC state and installation
of the succeeding gene regulatory network (Smith, 2017).
Ground State or Metastability
Both 2i/LIF and serum/LIF support feeder-free self-renewal
of ESCs competent for chimera formation and germline
transmission after injection into blastocysts. The ESC pop-
ulations in these two conditions are rather different, how-
ever. In serum/LIF the cultures are heterogeneous and
expression of many early lineage genes is detectable (Marks
et al., 2012). This is in part due to a degree of overt differen-
tiation, but even within the Oct4-positive pluripotent
compartment heterogeneity is apparent in morphology
and gene expression. Most strikingly, many of the pluripo-
tency transcription factors highlighted above, although
not Oct4 or Sox2, exhibit fluctuating expression (Cham-
bers et al., 2007; Filipczyk et al., 2015; Hayashi et al.,
2008; Toyooka et al., 2008). Cells that have downregulated
factors such as Nanog are more liable to differentiate
(Torres-Padilla and Chambers, 2014) and tend to be
excluded from chimeras (Alexandrova et al., 2016; Toyooka
et al., 2008). These observations have been interpreted as
reflecting an underlying metastability in pluripotent cells
that provides an opportunity for lineage specification (Hay-
ashi et al., 2008; Silva and Smith, 2008; Torres-Padilla and
Chambers, 2014). Yet in 2i/LIF, ESCs display substantially
uniform expression of pluripotency factors and negligible
levels of most lineage-affiliated genes (Marks et al., 2012;
Martello and Smith, 2014; Wray et al., 2010). Furthermore,
mosaicism is not evident in the newly formed pluripotent
embryonic epiblast between embryonic day 3.75 (E3.75)
and E4.5 (Acampora et al., 2016; Boroviak et al., 2015).Stem Cell Reports j Vol. 8 j 1457–1464 j June 6, 2017 1459
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contrary, we have proposed that mouse ESCs in 2i/LIF
occupy a ground state in which the pluripotency gene reg-
ulatory circuitry is maximally operative in all cells. This
manifests as an equipotent and effectively homogeneous
population of stem cells, exhibiting robust and sustained
symmetric self-renewal.
Naive and Primed Pluripotency
Pluripotency in the mouse embryo emerges in the mature
inner cell mass and persists until the onset of somitogene-
sis, a period of around 5 days. Yet ESCs have only been
derived directly from pre-implantation epiblast (Boroviak
et al., 2014; Brook and Gardner, 1997; Evans and Kaufman,
1981). Post-implantation epiblast cells differentiate or die
in any of the culture systems used for ESC propagation.
Alternative conditions comprising stimulation with FGF
and activin allowed derivation of pluripotent stem cells,
termed EpiSCs, from post-implantation embryos (Brons
et al., 2007; Tesar et al., 2007). EpiSCs are very different
from ESCs transcriptomically, epigenetically, metabolically
and functionally. They appear most related to the anterior
primitive streak epiblast of the late gastrula (Kojima et al.,
2014). Consistent with developmental trajectory, ESCs
can be differentiated into EpiSCs by changing culture con-
ditions whereas EpiSCs cannot, in general, revert to ESC
status, except by transgenic expression of ESC transcrip-
tion factors (Guo et al., 2009). The terms naive and primed
were introduced to denote the early and late phases, respec-
tively, of pluripotency in utero, and the corresponding ESC
and EpiSC states in vitro (Nichols and Smith, 2009). Primed
refers to the initiation of lineage specification in gastrula
stage epiblast cells and EpiSCs, reflected in varying degrees
of lineage-affiliated gene expression.
Significantly, the culture conditions applied to derive
EpiSC were essentially the same as those used for propa-
gating human pluripotent stem cells (Thomson et al.,
1998; Vallier et al., 2005). The source of this and other dif-
ferences betweenmouse ESCs andhumanpluripotent stem
cells had long been debated, but with the arrival of EpiSCs
the argument was largely settled; the major determinant is
developmental stage rather than species (Rossant, 2015).
This conclusion has been consolidated by the recent first
molecular characterization of post-implantation epiblast
in a non-human primate (Nakamura et al., 2016).
The primed status of human pluripotent stem cells may
be a major contributing factor to the variability observed
within and between different cell lines, which is also
apparent in mouse EpiSCs but much less so in ESCs. Partly
for this reason, efforts have been made to establish human
naive stem cells. Simple application of 2i/LIF is not suffi-
cient for human ESC derivation. Insufficiency of 2i/LIF
may be in part because Esrrb, a key factor downstream of1460 Stem Cell Reports j Vol. 8 j 1457–1464 j June 6, 2017GSK3 inhibition inmouse ESCs, is not expressed in the hu-
man naive epiblast (Blakeley et al., 2015). A second differ-
ence is that the response to LIF/Stat3 signaling is much
weaker in human than in mouse. Thus additional input
may be essential to sustain the human naive pluripotency
network in vitro. Recent reports indicate that supplementa-
tion of 2i/LIF with other pathway inhibitors can support
propagation of human pluripotent stem cells with tran-
scriptomic and epigenomic features of naive cells (Taka-
shima et al., 2014; Theunissen et al., 2014), and enable
their derivation directly from dissociated human inner
cell mass cells (Guo et al., 2016). While there is scope to
optimize the current culture systems, it seems likely that
human equivalents of rodent ESCs are attainable, albeit
with slightly different requirements.
Pluripotent Plateaus
Mouse ESCs maintained in 2i/LIF or serum/LIF exhibit
markedly different transcriptomes and epigenetic land-
scapes (Ficz et al., 2013; Habibi et al., 2013; Leitch et al.,
2013; Marks et al., 2012). ESCs in 2i/LIF remain similar to
E3.75–E4.5 pre-implantation epiblast from which they
are derived (Boroviak et al., 2014, 2015; Brook andGardner,
1997), whereas ESCs in serum/LIF diverge in both gene
expression and DNA methylation. They remain distinct
from EpiSCs, however. Notably, ESCs cultured in 2i/LIF or
serum/LIF are readily interconvertible simply by switching
culture conditions (Habibi et al., 2013; Joshi et al., 2015;
Marks et al., 2012; Martin Gonzalez et al., 2016). Although
some selection is apparent in the transition from serum,
the efficiency of conversion within one passage implies a
high degree of plasticity in ESCs. Similarly, aspects of the
primed EpiSC phenotype adjust between different culture
environments (Kim et al., 2013; Kurek et al., 2015; Sugi-
moto et al., 2015; Sumi et al., 2013; Tsakiridis et al., 2014;
Wu et al., 2015). A ‘‘plateau model’’ has been proposed to
explain such in vitro phenotype conversions (Chen et al.,
2015). The plateau comprises stem cell populations
captured in different culture conditions but representing
a discrete phase of development. Particular conditions
may maintain stem cells that diverge to a lesser or greater
degree from the in vivo context. It is always important,
therefore, to evaluate critically the resemblance of stem
cells in a given culture context to resident embryo cells.
Nonetheless, within the same plateau cells may readily be
interconverted because developmental proximity can su-
persede distinctions imposed by culture environments. In
contrast, conversion from the naive plateau to the primed
plateau is unidirectional, and reversion can only be
achieved efficiently via genetic or epigeneticmanipulation.
A striking distinction between naive and primed pluripo-
tent stem cells is their reliance on contrary signaling envi-
ronments. Naive cells are characterized by self-renewal in
Stem Cell Reports
Perspectivethe absence of FGF/Erk signaling and the presence of LIF/
Stat3 stimulation, whereas primed cells require FGF/Erk
and also stimulation of Smad2/3 by nodal, activin, or trans-
forming growth factor b (Brons et al., 2007; Tesar et al.,
2007; Vallier et al., 2005). Insulation of naive pluripotency
from Erk appears crucial in restricting developmental tran-
sition and thereby sustaining self-renewal (Smith, 2017).
A general feature of stem cell plateaus might be opposing
extrinsic conditions to those required by differentiating
progeny.
Naive ESCs from Other Mammals
A key remaining challenge in the field of ESC biology is
whether it is possible to establish authentic naive ESCs
from species other than the rodent, and if so, how. Avail-
ability of ESCs from other species would extend the power
of ESC-based genetic manipulation to large animal models
and to livestock enhancement. Although there are many
reports of embryo-derived cell cultures from different spe-
cies, so far only mouse and rat ESCs have been validated
by extensive contribution to adult chimeras after introduc-
tion into pre-implantation embryos.
It should be considered that naive pluripotency is a very
transient phase of development, and self-renewal capacity
is unlikely to be the direct target of evolutionary selection.
However, we hypothesize that the fundamental programof
pluripotency is conserved inmammals and that a core gene
regulatory network capable of sustaining self-renewal may
be retained. We suggest that the 2i culture system provides
a paradigm for construction in vitro environments to sus-
tain long-term stem cell self-renewal based on the princi-
ples of insulation from differentiation and reinforcement
of requisite metabolic pathways (Figure 1). Variations in
the 2i/LIF regimen have improved the derivation of rat
ESCs (Chen et al., 2013) and have enabled the generation
of candidate human naive pluripotent stem cells (Taka-
shima et al., 2014; Theunissen et al., 2014) that show spe-
cific transcription factor expression related to the mouse
ESC network (Dunn et al., 2014). Interestingly the require-
ment for GSK3 inhibition is diminished in rat and even
more so in human, but resistance to abolition of Erk
signaling is fully conserved. We anticipate that further re-
finements to prevent developmental progression entirely
will enable capture of germline-competent naive ESCs
from a broad range of mammals. We further speculate
that identifying and suppressing signals that direct devel-
opmental transition may be a general approach to the cap-
ture of self-renewing stem cells.
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